MWP
ABBV icon

Meriwether Wealth & Planning’s AbbVie ABBV Stock Holding History

Meriwether Wealth & Planning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$613K Sell
2,438
-29
-1% -$6.24K 0.3% 58
2026
Q1 		$537K Sell
2,467
-99
-4% -$22K 0.29% 57
2025
Q4 		$586K Sell
2,566
-211
-8% -$48.1K 0.33% 60
2025
Q3 		$643K Sell
2,777
-112
-4% -$22.8K 0.37% 51
2025
Q2 		$536K Sell
2,889
-56
-2% -$10.4K 0.34% 57
2025
Q1 		$617K Buy
2,945
+5
+0.2% +$972 0.4% 52
2024
Q4 		$522K Buy
+2,940
New +$541K 0.37% 55

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Meriwether Wealth & Planning's ABBV Position: Q2 2026 in Review

Meriwether Wealth & Planning reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $6.24K and leaving 2,438 shares worth $613K. The position accounts for 0.3% of the portfolio, ranked #58.

Meriwether Wealth & Planning first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $643K in Q3 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Meriwether Wealth & Planning held 2,438 shares of AbbVie worth $613K as of Q2 2026.
  • Meriwether Wealth & Planning sold 29 AbbVie shares in Q2 2026, an estimated $6.24K.
  • AbbVie made up 0.3% of Meriwether Wealth & Planning's portfolio in Q2 2026, its #58 holding.
  • Meriwether Wealth & Planning first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Meriwether Wealth & Planning's AbbVie position peaked at $643K in Q3 2025.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q2 2026, filed 8 Jul 2026.